Last edition
News about "Verona Pharma "
Merck Completes Acquisition of Verona Pharma
The acquisition of Verona Pharma strengthens Merck’s cardio-pulmonary portfolio with addition of Ohtuvayre (ensifentrine), a first-in-class COPD maintenance treatment, that is expected to grow into the next decade.
Verona Pharma | 08/10/2025 | By Dineshwori
Merck to Acquire Verona Pharma for USD 10 Billion to Expand Cardio-Pulmonary Portfolio
Merck, through a subsidiary, will acquire Verona Pharma for USD 107 per American Depository Share (ADS), each of which represents eight shares of Verona Pharma, for a total transaction value of approximately USD 10 billion.
Verona Pharma | 10/07/2025 | By Dineshwori | 277
Verona Pharma Secures US FDA Approval of Ohtuvayre
Verona Pharma has announced that the US Food and Drug Administration (FDA) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.
Verona Pharma | 27/06/2024 | By Aishwarya | 756
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy